Melatonin: A well-documented antioxidant with conditional pro-oxidant actions

Journal of Pineal Research

Volumn 57, Issue 2, 2014, Pages 131-146

  Zhang, Hong Mei ^a   Zhang, Yiqiang ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

antioxidant; free radicals; melatonin; mitochondria; pro oxidant; reactive nitrogen species; reactive oxygen species

Indexed keywords

CALMODULIN; DNA; FREE RADICAL; LIPID; MELATONIN; REACTIVE OXYGEN METABOLITE; UBIQUINOL CYTOCHROME C REDUCTASE; ANTIOXIDANT; REACTIVE NITROGEN SPECIES;

ANTIOXIDANT ACTIVITY; CANCER CELL CULTURE; ENZYME ACTIVATION; GENE CONTROL; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE POTENTIAL; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; ANIMAL; METABOLISM; PHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; HUMANS; MELATONIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES;

EID: 84925835510     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12162     Document Type: Review

References (214)

1. Lerner AB, Case JD, Takahashi Y, et al. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Am Chem Soc 1958; 80: 2587.
2. Reiter RJ, Tan DX, Rosales-Corral S, et al. The universal nature, unequal distribution and antioxidant functions of melatonin and its derivatives. Mini Rev Med Chem 2013; 13: 373-384.
3. Reiter RJ, Tan DX, Fuentes-Broto L,. Melatonin: a multitasking molecule. Prog Brain Res 2010; 181: 127-151.
4. Marczynski TJ, Yamaguchi N, Ling GM, et al. Sleep induced by the administration of melatonin (5-methoxyn-acetyltryptamine) to the hypothalamus in unrestrained cats. Experientia 1964; 20: 435-437.
5. Reiter RJ,. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 1991; 79: C153-C158.
6. Reiter RJ,. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991; 12: 151-180.
7. Reiter RJ,. The melatonin rhythm: both a clock and a calendar. Experientia 1993; 49: 654-664. (Pubitemid 23256791)
8. Reiter RJ, Tan DX, Burkhardt S,. Reactive oxygen and nitrogen species and cellular and organismal decline: amelioration with melatonin. Mech Ageing Dev 2002; 123: 1007-1019. (Pubitemid 34603084)
9. Tan DX, Manchester LC, Terron MP, et al. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42. (Pubitemid 44924323)
10. Pablos MI, Reiter RJ, Ortiz GG, et al. Rhythms of glutathione peroxidase and glutathione reductase in brain of chick and their inhibition by light. Neurochem Int 1998; 32: 69-75. (Pubitemid 28020239)
11. Barlow-Walden LR, Reiter RJ, Abe M, et al. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 1995; 26: 497-502.
12. Stankov B, Reiter RJ,. Melatonin receptors: current status, facts, and hypotheses. Life Sci 1990; 46: 971-982. (Pubitemid 20150552)
13. Dubocovich ML, Markowska M,. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 2005; 27: 101-110. (Pubitemid 41558442)
14. Carrillo-Vico A, Guerrero JM, Lardone PJ, et al. A review of the multiple actions of melatonin on the immune system. Endocrine 2005; 27: 189-200. (Pubitemid 41558451)
15. Tan DX, Manchester LC, Terron MP, et al. Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance. J Pineal Res 2007; 43: 317-320. (Pubitemid 47512273)
16. Luchetti F, Canonico B, Betti M, et al. Melatonin signaling and cell protection function. FASEB J 2010; 24: 3603-3624.
17. Radogna F, Sestili P, Martinelli C, et al. Lipoxygenase-mediated pro-radical effect of melatonin via stimulation of arachidonic acid metabolism. Toxicol Appl Pharmacol 2009; 238: 170-177.
18. Albertini MC, Radogna F, Accorsi A, et al. Intracellular pro-oxidant activity of melatonin deprives U937 cells of reduced glutathione without affecting glutathione peroxidase activity. Ann N Y Acad Sci 2006; 1091: 10-16. (Pubitemid 47092220)
19. Buyukavci M, Ozdemir O, Buck S, et al. Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam Clin Pharmacol 2006; 20: 73-79.
20. Clapp-Lilly KL, Smith MA, Perry G, et al. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. NeuroReport 2001; 12: 1277-1280. (Pubitemid 32374758)
21. Radogna F, Paternoster L, De Nicola M, et al. Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes. Toxicol Appl Pharmacol 2009; 239: 37-45.
22. Girish KS, Paul M, Thushara RM, et al. Melatonin elevates apoptosis in human platelets via ROS mediated mitochondrial damage. Biochem Biophys Res Commun 2013; 438: 198-204.
23. Zhang HM, Zhang Y, Zhang BX,. The role of mitochondrial complex III in melatonin-induced ROS production in cultured mesangial cells. J Pineal Res 2011; 50: 78-82.
24. Zhang H, Zhang HM, Wu LP, et al. Impaired mitochondrial complex III and melatonin responsive reactive oxygen species generation in kidney mitochondria of db/db mice. J Pineal Res 2011; 51: 338-344.
25. Bejarano I, Espino J, Barriga C, et al. Pro-oxidant effect of melatonin in tumour leucocytes: relation with its cytotoxic and pro-apoptotic effects. Basic Clin Pharmacol Toxicol 2011; 108: 14-20.
26. Medina-Navarro R, Duran-Reyes G, Hicks JJ,. Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocr Res 1999; 25: 263-280.
27. Wolfler A, Caluba HC, Abuja PM, et al. Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett 2001; 502: 127-131. (Pubitemid 32728274)
28. Osseni RA, Rat P, Bogdan A, et al. Evidence of prooxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 2000; 68: 387-399. (Pubitemid 32011892)
29. Valko M, Leibfritz D, Moncol J, et al. Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 2007; 39: 44-84. (Pubitemid 44566469)
30. Finkel T, Holbrook NJ,. Oxidants, oxidative stress and the biology of ageing. Nature 2000; 408: 239-247.
31. Reiter RJ, Tan DX, Manchester LC, et al. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 2001; 34: 237-256. (Pubitemid 33615836)
32. Patel RP, Mcandrew J, Sellak H, et al. Biological aspects of reactive nitrogen species. Biochim Biophys Acta 1999; 1411: 385-400. (Pubitemid 29221963)
33. Malorni W, Pietraforte D,. Focusing at the double edged sword of redox imbalance: signals for cell survival or for cell death? Antioxid Redox Signal 2014; 21: 52-55.
34. Chandra J, Samali A, Orrenius S,. Triggering and modulation of apoptosis by oxidative stress. Free Radic Biol Med 2000; 29: 323-333.
35. Sinha K, Das J, Pal PB, et al. Oxidative stress: the mitochondria- dependent and mitochondria-independent pathways of apoptosis. Arch Toxicol 2013; 87: 1157-1180.
36. Lu T, Finkel T,. Free radicals and senescence. Exp Cell Res 2008; 314: 1918-1922.
37. Dreher D, Junod AF,. Role of oxygen free radicals in cancer development. Eur J Cancer 1996; 32A: 30-38.
38. Moore MN,. Autophagy as a second level protective process in conferring resistance to environmentally-induced oxidative stress. Autophagy 2008; 4: 254-256. (Pubitemid 351231195)
39. David SS, O'shea VL, Kundu S,. Base-excision repair of oxidative DNA damage. Nature 2007; 447: 941-950. (Pubitemid 46975761)
40. Voeikov VL,. Reactive oxygen species-(ROS) pathogens or sources of vital energy? Part 1. ROS in normal and pathologic physiology of living systems. J Altern Complement Med 2006; 12: 111-118.
41. Kohchi C, Inagawa H, Nishizawa T, et al. ROS and innate immunity. Anticancer Res 2009; 29: 817-821.
42. Shepherd VL,. The role of the respiratory burst of phagocytes in host defense. Semin Respir Infect 1986; 1: 99-106.
43. Nathan CF, Hibbs JB Jr,. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
44. D'Autreaux B, Toledano MB,. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nat Rev Mol Cell Biol 2007; 8: 813-824. (Pubitemid 47462134)
45. Allen RG, Tresini M,. Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28: 463-499. (Pubitemid 30110662)
46. Cross JV, Templeton DJ,. Regulation of signal transduction through protein cysteine oxidation. Antioxid Redox Signal 2006; 8: 1819-1827. (Pubitemid 44726354)
47. Murad F,. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system. Adv Pharmacol 1994; 26: 19-33.
48. Melchiorri D, Reiter RJ, Sewerynek E, et al. Paraquat toxicity and oxidative damage. Reduction by melatonin. Biochem Pharmacol 1996; 51: 1095-1099.
49. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
50. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
51. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
52. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin: detoxification of oxygen and nitrogen-based toxic reactants. Adv Exp Med Biol 2003; 527: 539-548. (Pubitemid 38197683)
53. Rodriguez C, Mayo JC, Sainz RM, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 2004; 36: 1-9. (Pubitemid 38130283)
54. Pozo D, Reiter RJ, Calvo JR, et al. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 1994; 55: PL455-PL460. (Pubitemid 24347808)
55. Pozo D, Reiter RJ, Calvo JR, et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997; 65: 430-442. (Pubitemid 27190697)
56. Martin M, Macias M, Escames G, et al. Melatonin-induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 2000; 28: 242-248. (Pubitemid 30255377)
57. Acuna-Castroviejo D, Martin M, Macias M, et al. Melatonin, mitochondria, and cellular bioenergetics. J Pineal Res 2001; 30: 65-74. (Pubitemid 32176208)
58. Leon J, Acuna-Castroviejo D, Sainz RM, et al. Melatonin and mitochondrial function. Life Sci 2004; 75: 765-790. (Pubitemid 38737416)
59. Acuna-Castroviejo D, Lopez LC, Escames G, et al. Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem 2011; 11: 221-240.
60. Menendez-Pelaez A, Reiter RJ,. Distribution of melatonin in mammalian tissues: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15: 59-69. (Pubitemid 24028611)
61. Menendez-Pelaez A, Poeggeler B, Reiter RJ, et al. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem 1993; 53: 373-382. (Pubitemid 24043036)
62. Venegas C, Garcia JA, Escames G, et al. Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 2012; 52: 217-227.
63. Poeggeler B, Saarela S, Reiter RJ, et al. Melatonin-a highly potent endogenous radical scavenger and electron donor: new aspects of the oxidation chemistry of this indole accessed in vitro. Ann N Y Acad Sci 1994; 738: 419-420.
64. Matuszak Z, Reszka K, Chignell CF,. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 1997; 23: 367-372. (Pubitemid 27276772)
65. Susa N, Ueno S, Furukawa Y, et al. Potent protective effect of melatonin on chromium(VI)-induced DNA single-strand breaks, cytotoxicity, and lipid peroxidation in primary cultures of rat hepatocytes. Toxicol Appl Pharmacol 1997; 144: 377-384. (Pubitemid 27268360)
66. Stasica P, Ulanski P, Rosiak JM,. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998; 25: 65-66. (Pubitemid 28319918)
67. Roberts JE, Hu DN, Wishart JF,. Pulse radiolysis studies of melatonin and chloromelatonin. J Photochem Photobiol B 1998; 42: 125-132. (Pubitemid 28142333)
68. Rath MC, Mahal HS, Mukherjee T,. Photophysics of melatonin in different environments. Photochem Photobiol 1999; 69: 294-300. (Pubitemid 129554854)
69. Pahkla R, Zilmer M, Kullisaar T, et al. Comparison of the antioxidant activity of melatonin and pinoline in vitro. J Pineal Res 1998; 24: 96-101. (Pubitemid 28168321)
70. Li XJ, Zhang LM, Gu J, et al. Melatonin decreases production of hydroxyl radical during cerebral ischemia-reperfusion. Zhongguo Yao Li Xue Bao 1997; 18: 394-396. (Pubitemid 27389438)
71. Bromme HJ, Morke W, Peschke D, et al. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 2000; 29: 201-208.
72. Tan DX, Hardeland R, Manchester LC, et al. Cyclic-3-hydroxymelatonin (C3HOM), a potent antioxidant, scavenges free radicals and suppresses oxidative reactions. Curr Med Chem 2014; 21: 1557-1565.
73. Galano A, Tan DX, Reiter RJ,. Cyclic 3-hydroxymelatonin, a key metabolite enhancing the peroxyl radical scavenging activity of melatonin. Roy Soc Chem Adv 2014; 4: 5220-5227.
74. Tan DX, Manchester LC, Reiter RJ, et al. A novel melatonin metabolite, cyclic 3-hydroxymelatonin: a biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 1998; 253: 614-620. (Pubitemid 29039192)
75. Tan DX, Manchester LC, Reiter RJ, et al. Cyclic 3-hydroxymelatonin: a melatonin metabolite generated as a result of hydroxyl radical scavenging. Biol Signals Recept 1999; 8: 70-74. (Pubitemid 29132385)
76. Hirata F, Hayaishi O, Tokuyama T, et al. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 1974; 249: 1311-1313.
77. Tan DX, Manchester LC, Reiter RJ, et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000; 29: 1177-1185.
78. Tan DX, Manchester LC, Burkhardt S, et al. N1-acetyl-N2-formyl-5- methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J 2001; 15: 2294-2296.
79. Maharaj DS, Anoopkumar-Dukie S, Glass BD, et al. The identification of the UV degradants of melatonin and their ability to scavenge free radicals. J Pineal Res 2002; 32: 257-261. (Pubitemid 34478288)
80. Ressmeyer AR, Mayo JC, Zelosko V, et al. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction. Redox Rep 2003; 8: 205-213. (Pubitemid 37236233)
81. Guenther AL, Schmidt SI, Laatsch H, et al. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005; 39: 251-260. (Pubitemid 41337805)
82. Tan DX, Reiter RJ, Manchester LC, et al. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2002; 2: 181-197.
83. Reiter RJ, Paredes SD, Manchester LC, et al. Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 2009; 44: 175-200.
84. Paredes SD, Reiter RJ,. Melatonin: helping cells cope with oxidative disaster. Cell Membr Free Radic Res 2010; 2: 99-111.
85. Mahal HS, Sharma HS, Mukherjee T,. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 1999; 26: 557-565. (Pubitemid 29146258)
86. Scaiano JC,. Exploratory laser flash photolysis study of free radical reactions and magnetic field effects in melatonin chemistry. J Pineal Res 1995; 19: 189-195.
87. Zhang H, Squadrito GL, Pryor WA,. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem Biophys Res Commun 1998; 251: 83-87. (Pubitemid 28498067)
88. Zhang H, Squadrito GL, Uppu R, et al. Reaction of peroxynitrite with melatonin: a mechanistic study. Chem Res Toxicol 1999; 12: 526-534. (Pubitemid 29282924)
89. Zang LY, Cosma G, Gardner H, et al. Scavenging of reactive oxygen species by melatonin. Biochim Biophys Acta 1998; 1425: 469-477. (Pubitemid 28546681)
90. Poeggeler B, Reiter RJ, Tan DX, et al. Melatonin, hydroxyl radical-mediated oxidative damage, and aging: a hypothesis. J Pineal Res 1993; 14: 151-168. (Pubitemid 23253014)
91. Cagnoli CM, Atabay C, Kharlamova E, et al. Melatonin protects neurons from singlet oxygen-induced apoptosis. J Pineal Res 1995; 18: 222-226.
92. Noda Y, Mori A, Liburdy R, et al. Melatonin and its precursors scavenge nitric oxide. J Pineal Res 1999; 27: 159-163. (Pubitemid 29487960)
93. Blanchard B, Pompon D, Ducrocq C,. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 2000; 29: 184-192.
94. Gilad E, Cuzzocrea S, Zingarelli B, et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60: PL169-PL174. (Pubitemid 27087273)
95. Mayo JC, Tan DX, Sainz RM, et al. Oxidative damage to catalase induced by peroxyl radicals: functional protection by melatonin and other antioxidants. Free Radic Res 2003; 37: 543-553. (Pubitemid 36410896)
96. Cuzzocrea S, Zingarelli B, Costantino G, et al. Protective effect of melatonin in a non-septic shock model induced by zymosan in the rat. J Pineal Res 1998; 25: 24-33. (Pubitemid 28319913)
97. Cuzzocrea S, Costantino G, Caputi AP,. Protective effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in a non-septic shock model induced by zymosan in the rat. J Pineal Res 1998; 25: 78-85. (Pubitemid 28392103)
98. El-Sokkary GH, Reiter RJ, Cuzzocrea S, et al. Role of melatonin in reduction of lipid peroxidation and peroxynitrite formation in non-septic shock induced by zymosan. Shock 1999; 12: 402-408.
99. Dugo L, Serraino I, Fulia F, et al. Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation. J Pineal Res 2001; 31: 76-84. (Pubitemid 32626049)
100. Yin J, Liu YH, Xu YF, et al. Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the overactivation of protein kinases in rat brain. J Pineal Res 2006; 41: 124-129. (Pubitemid 44141746)
101. Antolin I, Rodriguez C, Sainz RM, et al. Neurohormone melatonin prevents cell damage: effect on gene expression for antioxidant enzymes. FASEB J 1996; 10: 882-890. (Pubitemid 26184166)
102. Mayo JC, Sainz RM, Antoli I, et al. Melatonin regulation of antioxidant enzyme gene expression. Cell Mol Life Sci 2002; 59: 1706-1713. (Pubitemid 35346974)
103. Tang YP, Ma YL, Chao CC, et al. Enhanced glial cell line-derived neurotrophic factor mRNA expression upon (-)-deprenyl and melatonin treatments. J Neurosci Res 1998; 53: 593-604. (Pubitemid 28380800)
104. Gomez M, Esparza JL, Nogues MR, et al. Pro-oxidant activity of aluminum in the rat hippocampus: gene expression of antioxidant enzymes after melatonin administration. Free Radic Biol Med 2005; 38: 104-111. (Pubitemid 39626915)
105. Esparza JL, Gomez M, Rosa Nogues M, et al. Melatonin reduces oxidative stress and increases gene expression in the cerebral cortex and cerebellum of aluminum-exposed rats. J Pineal Res 2005; 39: 129-136. (Pubitemid 41140750)
106. Kotler M, Rodriguez C, Sainz RM, et al. Melatonin increases gene expression for antioxidant enzymes in rat brain cortex. J Pineal Res 1998; 24: 83-89. (Pubitemid 28168319)
107. Fischer TW, Kleszczynski K, Hardkop LH, et al. Melatonin enhances antioxidative enzyme gene expression (CAT, GPx, SOD), prevents their UVR-induced depletion, and protects against the formation of DNA damage (8-hydroxy-2-deoxyguanosine) in ex vivo human skin. J Pineal Res 2013; 54: 303-312.
108. Wang F, Tian X, Zhang L, et al. Melatonin promotes the in vitro development of pronuclear embryos and increases the efficiency of blastocyst implantation in murine. J Pineal Res 2013; 55: 267-274.
109. Liu X, Xu Y, Chen S, et al. Rescue of proinflammatory cytokine-inhibited chondrogenesis by the antiarthritic effect of melatonin in synovium mesenchymal stem cells via suppression of reactive oxygen species and matrix metalloproteinases. Free Radic Biol Med 2014; 68: 234-246.
110. Mauriz JL, Molpeceres V, Garcia-Mediavilla MV, et al. Melatonin prevents oxidative stress and changes in antioxidant enzyme expression and activity in the liver of aging rats. J Pineal Res 2007; 42: 222-230. (Pubitemid 46365058)
111. Bettahi I, Pozo D, Osuna C, et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996; 20: 205-210. (Pubitemid 126733163)
112. Leon J, Vives F, Crespo E, et al. Modification of nitric oxide synthase activity and neuronal response in rat striatum by melatonin and kynurenine derivatives. J Neuroendocrinol 1998; 10: 297-302. (Pubitemid 28177351)
113. Leon J, Escames G, Rodriguez MI, et al. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 2006; 98: 2023-2933.
114. Crespo E, Macias M, Pozo D, et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13: 1537-1546. (Pubitemid 29411787)
115. Tomas-Zapico C, Coto-Montes A,. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 2005; 39: 99-104. (Pubitemid 41140746)
116. Reiter RJ, Paredes SD, Korkmaz A, et al. Melatonin combats molecular terrorism at the mitochondrial level. Interdiscip Toxicol 2008; 1: 137-149.
117. Acuna-Castroviejo D, Escames G, Rodriguez MI, et al. Melatonin role in the mitochondrial function. Front Biosci 2007; 12: 947-963. (Pubitemid 46846869)
118. Leon J, Acuna-Castroviejo D, Escames G, et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38: 1-9. (Pubitemid 40139304)
119. Acuna-Castroviejo D, Escames G, Leon J, et al. Mitochondrial regulation by melatonin and its metabolites. Adv Exp Med Biol 2003; 527: 549-557. (Pubitemid 38197684)
120. Tan DX, Manchester LC, Liu X, et al. Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res 2013; 54: 127-238.
121. Acuna-Castroviejo D, Escames G, Carazo A, et al. Melatonin, mitochondrial homeostasis and mitochondrial-related diseases. Curr Top Med Chem 2002; 2: 133-151.
122. Acuna-Castroviejo D, Escames G, Lopez LC, et al. Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine 2005; 27: 159-168. (Pubitemid 41558448)
123. Inarrea P, Casanova A, Alava MA, et al. Melatonin and steroid hormones activate intermembrane Cu,Zn-superoxide dismutase by means of mitochondrial cytochrome P450. Free Radic Biol Med 2011; 50: 1575-1581.
124. Garcia JJ, Reiter RJ, Pie J, et al. Role of pinoline and melatonin in stabilizing hepatic microsomal membranes against oxidative stress. J Bioenerg Biomembr 1999; 31: 609-616. (Pubitemid 30082903)
125. Prunet-Marcassus B, Ambid L, Viguerie-Bascands N, et al. Evidence for a direct effect of melatonin on mitochondrial genome expression of Siberian hamster brown adipocytes. J Pineal Res 2001; 30: 108-115. (Pubitemid 32176213)
126. Andrabi SA, Sayeed I, Siemen D, et al. Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 2004; 18: 869-871.
127. 2+ stress in astrocyte. J Pineal Res 2011; 50: 427-435.
128. Radogna F, Cristofanon S, Paternoster L, et al. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2. J Pineal Res 2008; 44: 316-325. (Pubitemid 351392945)
129. Dragicevic N, Copes N, O'Neal-Moffitt G, et al. Melatonin treatment restores mitochondrial function in Alzheimer's mice: a mitochondrial protective role of melatonin membrane receptor signaling. J Pineal Res 2011; 51: 75-86.
130. Elmahallawy EK, Jimenez-Aranda A, Martinez AS, et al. Activity of melatonin against Leishmania infantum promastigotes by mitochondrial dependent pathway. Chem Biol Interact 2014; 220: 84-93.
131. Bizzarri M, Proietti S, Cucina A, et al. Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review. Expert Opin Ther Targets 2013; 17: 1483-1496.
132. Rodriguez C, Martin V, Herrera F, et al. Mechanisms involved in the pro-apoptotic effect of melatonin in cancer cells. Int J Mol Sci 2013; 14: 6597-6613.
133. Karbownik M, Tan D, Manchester LC, et al. Renal toxicity of the carcinogen delta-aminolevulinic acid: antioxidant effects of melatonin. Cancer Lett 2000; 161: 1-7.
134. Reiter RJ, Tan DX, Manchester LC, et al. Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci 2002; 959: 238-250. (Pubitemid 34457565)
135. Yamamoto HA, Mohanan PV,. Melatonin attenuates brain mitochondria DNA damage induced by potassium cyanide in vivo and in vitro. Toxicology 2002; 179: 29-36. (Pubitemid 35245461)
136. Chen LJ, Gao YQ, Li XJ, et al. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 2005; 39: 34-42.
137. Guha M, Maity P, Choubey V, et al. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res 2007; 43: 372-381. (Pubitemid 47512269)
138. Petrosillo G, Di Venosa N, Pistolese M, et al. Protective effect of melatonin against mitochondrial dysfunction associated with cardiac ischemia- reperfusion: role of cardiolipin. FASEB J 2006; 20: 269-276. (Pubitemid 44933174)
139. Lopez LC, Escames G, Ortiz F, et al. Melatonin restores the mitochondrial production of ATP in septic mice. Neuro Endocrinol Lett 2006; 27: 623-630. (Pubitemid 46050020)
140. Zhang H, Liu D, Wang X, et al. Melatonin improved rat cardiac mitochondria and survival rate in septic heart injury. J Pineal Res 2013; 55: 1-6.
141. Kashani IR, Rajabi Z, Akbari M, et al. Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Exp Brain Res 2014 [Epub ahead of print].
142. Song N, Kim AJ, Kim HJ, et al. Melatonin suppresses doxorubicin-induced premature senescence of A549 lung cancer cells by ameliorating mitochondrial dysfunction. J Pineal Res 2012; 53: 335-343.
143. Rodriguez MI, Escames G, Lopez LC, et al. Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 2008; 43: 749-756.
144. Okatani Y, Wakatsuki A, Reiter RJ,. Melatonin protects hepatic mitochondrial respiratory chain activity in senescence-accelerated mice. J Pineal Res 2002; 32: 143-148. (Pubitemid 34309880)
145. Rodriguez MI, Carretero M, Escames G, et al. Chronic melatonin treatment prevents age-dependent cardiac mitochondrial dysfunction in senescence- accelerated mice. Free Radic Res 2007; 41: 15-24. (Pubitemid 44896871)
146. Petrosillo G, Fattoretti P, Matera M, et al. Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection. Rejuvenation Res 2008; 11: 935-943.
147. Carretero M, Escames G, Lopez LC, et al. Long-term melatonin administration protects brain mitochondria from aging. J Pineal Res 2009; 47: 192-200.
148. Acuna-Castroviejo D, Carretero M, Doerrier C, et al. Melatonin protects lung mitochondria from aging. Age 2012; 34: 681-692.
149. Petrosillo G, Moro N, Ruggiero FM, et al. Melatonin inhibits cardiolipin peroxidation in mitochondria and prevents the mitochondrial permeability transition and cytochrome c release. Free Radic Biol Med 2009; 47: 969-974.
150. Petrosillo G, De Benedictis V, Ruggiero FM, et al. Decline in cytochrome c oxidase activity in rat-brain mitochondria with aging. Role of peroxidized cardiolipin and beneficial effect of melatonin. J Bioenerg Biomembr 2013; 45: 431-440.
151. Luchetti F, Canonico B, Mannello F, et al. Melatonin reduces early changes in intramitochondrial cardiolipin during apoptosis in U937 cell line. Toxicol In Vitro 2007; 21: 293-301. (Pubitemid 46205074)
152. Martin M, Macias M, Leon J, et al. Melatonin increases the activity of the oxidative phosphorylation enzymes and the production of ATP in rat brain and liver mitochondria. Int J Biochem Cell Biol 2002; 34: 348-357. (Pubitemid 34164278)
153. Reiter RJ,. Melatonin: lowering the high price of free radicals. News Physiol Sci 2000; 15: 246-250.
154. De Atenor MS, De Romero IR, Brauckmann E, et al. Effects of the pineal gland and melatonin on the metabolism of oocytes in vitro and on ovulation in Bufo arenarum. J Exp Zool 1994; 268: 436-441. (Pubitemid 2065249)
155. Reyes-Toso CF, Ricci CR, De Mignone IR, et al. In vitro effect of melatonin on oxygen consumption in liver mitochondria of rats. Neuro Endocrinol Lett 2003; 24: 341-344. (Pubitemid 37368845)
156. Reyes-Toso CF, Rebagliati IR, Ricci CR, et al. Effect of melatonin treatment on oxygen consumption by rat liver mitochondria. Amino Acids 2006; 31: 299-302. (Pubitemid 44537055)
157. Jou MJ, Peng TI, Yu PZ, et al. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 2007; 43: 389-403.
158. Jou MJ, Peng TI, Reiter RJ, et al. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004; 37: 55-70. (Pubitemid 38969021)
159. Reiter RJ, Tan DX, Terron MP, et al. Melatonin and its metabolites: new findings regarding their production and their radical scavenging actions. Acta Biochim Pol 2007; 54: 1-9. (Pubitemid 46481811)
160. Bonnefont-Rousselot D, Collin F, Jore D, et al. Reaction mechanism of melatonin oxidation by reactive oxygen species in vitro. J Pineal Res 2011; 50: 328-335.
161. Silva SO, Rodrigues MR, Carvalho SR, et al. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes. J Pineal Res 2004; 37: 171-175. (Pubitemid 39274114)
162. Semak I, Naumova M, Korik E, et al. A novel metabolic pathway of melatonin: oxidation by cytochrome C. Biochemistry 2005; 44: 9300-9307. (Pubitemid 40934380)
163. Niu S, Li F, Tan DX, et al. Analysis of N1-acetyl-N2-formyl-5- methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in
164. Hardeland R, Tan DX, Reiter RJ,. Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res 2009; 47: 109-126.
165. Liu X, Chen Z, Chua CC, et al. Melatonin as an effective protector against doxorubicin-induced cardiotoxicity. Am J Physiol Heart Circ Physiol 2002; 283: H254-H263. (Pubitemid 34705347)
166. Burkhardt S, Reiter RJ, Tan DX, et al. DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol 2001; 33: 775-783. (Pubitemid 32524175)
167. Onuki J, Almeida EA, Medeiros MH, et al. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005; 38: 107-115. (Pubitemid 40293235)
168. Janjetovic Z, Nahmias ZP, Hanna S, et al. Melatonin and its metabolites ameliorate UVB-induced damages in human epidermal keratinocytes. J Pineal Res 2014; 57: 90-102.
169. Manda K, Ueno M, Anzai K,. AFMK, a melatonin metabolite, attenuates X-ray-induced oxidative damage to DNA, proteins and lipids in mice. J Pineal Res 2007; 42: 386-393. (Pubitemid 46581663)
170. Schaefer M, Hardeland R,. The melatonin metabolite N-acetyl-5- methoxykynuramine is a potent singlet oxygen scavenger. J Pineal Res 2009; 46: 49-52.
171. Hardeland R,. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-130. (Pubitemid 41558444)
172. Tapias V, Escames G, Lopez LC, et al. Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res 2009; 87: 3002-3010.
173. Entrena A, Camacho ME, Carrion MD, et al. Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 2005; 48: 8174-8181. (Pubitemid 43032526)
174. Radogna F, Diederich M, Ghibelli L,. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol 2010; 80: 1844-1852.
175. Mauriz JL, Collado PS, Veneroso C, et al. A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res 2013; 54: 1-14.
176. Kelly RW, Amato F, Seamark RF,. N-acetyl-5-methoxy kynurenamine, a brain metabolite of melatonin, is a potent inhibitor of prostaglandin biosynthesis. Biochem Biophys Res Commun 1984; 121: 372-379. (Pubitemid 14117162)
177. Mayo JC, Sainz RM, Tan DX, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol 2005; 165: 139-149. (Pubitemid 40984631)
178. Budu A, Peres R, Bueno VB, et al. N1-acetyl-N2-formyl-5-methoxykynuramine modulates the cell cycle of malaria parasites. J Pineal Res 2007; 42: 261-266. (Pubitemid 46365063)
179. Cristofanon S, Uguccioni F, Cerella C, et al. Intracellular prooxidant activity of melatonin induces a survival pathway involving NF-kappaB activation. Ann N Y Acad Sci 2009; 1171: 472-478.
180. Fu J, Zhao SD, Liu HJ, et al. Melatonin promotes proliferation and differentiation of neural stem cells subjected to hypoxia in vitro. J Pineal Res 2011; 51: 104-112.
181. Cui P, Yu M, Peng X, et al. Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression. J Pineal Res 2012; 52: 236-243.
182. Kojima T, Mochizuki C, Mitaka T, et al. Effects of melatonin on proliferation, oxidative stress and Cx32 gap junction protein expression in primary cultures of adult rat hepatocytes. Cell Struct Funct 1997; 22: 347-356. (Pubitemid 27365905)
183. James P, Vorherr T, Carafoli E,. Calmodulin-binding domains: just two faced or multi-faceted? Trends Biochem Sci 1995; 20: 38-42.
184. Benitez-King G, Huerto-Delgadillo L, Anton-Tay F,. Binding of 3H-melatonin to calmodulin. Life Sci 1993; 53: 201-207.
185. Ford-Hutchinson AW, Gresser M, Young RN,. 5-Lipoxygenase. Annu Rev Biochem 1994; 63: 383-417. (Pubitemid 24218638)
186. Dennis EA, Cao J, Hsu YH, et al. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011; 111: 6130-6185.
187. Jenkins CM, Wolf MJ, Mancuso DJ, et al. Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function. J Biol Chem 2001; 276: 7129-7135.
188. Romero MP, Garcia-Perganeda A, Guerrero JM, et al. Membrane-bound calmodulin in Xenopus laevis oocytes as a novel binding site for melatonin. FASEB J 1998; 12: 1401-1408. (Pubitemid 28475582)
189. Anton-Tay F, Martinez I, Tovar R, et al. Modulation of the subcellular distribution of calmodulin by melatonin in MDCK cells. J Pineal Res 1998; 24: 35-42. (Pubitemid 28161019)
190. Soto-Vega E, Meza I, Ramirez-Rodriguez G, et al. Melatonin stimulates calmodulin phosphorylation by protein kinase C. J Pineal Res 2004; 37: 98-106. (Pubitemid 39120213)
191. Sarti P, Magnifico MC, Altieri F, et al. New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide. Int J Mol Sci 2013; 14: 11259-11276.
192. Martinis P, Zago L, Maritati M, et al. Interactions of melatonin with mammalian mitochondria. Reducer of energy capacity and amplifier of permeability transition. Amino Acids 2012; 42: 1827-1837.
193. Lopez A, Garcia JA, Escames G, et al. Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 2009; 46: 188-198.
194. Arese M, Magnifico MC, Mastronicola D, et al. Nanomolar melatonin enhances nNOS expression and controls HaCaT-cells bioenergetics. IUBMB Life 2012; 64: 251-258.
195. Kabore AF, Johnston JB, Gibson SB,. Changes in the apoptotic and survival signaling in cancer cells and their potential therapeutic implications. Curr Cancer Drug Targets 2004; 4: 147-163. (Pubitemid 38332553)
196. Pelicano H, Carney D, Huang P,. ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 2004; 7: 97-110. (Pubitemid 38736063)
197. Gogvadze V, Zhivotovsky B, Orrenius S,. The Warburg effect and mitochondrial stability in cancer cells. Mol Aspects Med 2010; 31: 60-74.
198. Sainz RM, Mayo JC, Rodriguez C, et al. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003; 60: 1407-1426. (Pubitemid 36900523)
199. Karasek M, Reiter RJ,. Melatonin and aging. Neuro Endocrinol Lett 2002; 23 (Suppl. 1): 14-16. (Pubitemid 34495375)
200. Teshima Y, Takahashi N, Nishio S, et al. Production of reactive oxygen species in the diabetic heart. Roles of mitochondria and NADPH oxidase. Circ J 2014; 78: 300-306.
201. Abe M, Reiter RJ, Orhii PB, et al. Inhibitory effect of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 1994; 17: 94-100.
202. Cheshchevik VT, Dremza IK, Lapshina EA, et al. Corrections by melatonin of liver mitochondrial disorders under diabetes and acute intoxication in rats. Cell Biochem Funct 2011; 29: 481-488.
203. Reiter RJ, Tan DX, Korkmaz A, et al. Obesity and metabolic syndrome: association with chronodisruption, sleep deprivation, and melatonin suppression. Ann Med 2012; 44: 564-577.
204. Sharman EH, Sharman KG, Bondy SC,. Extended exposure to dietary melatonin reduces tumor number and size in aged male mice. Exp Gerontol 2011; 46: 18-22.
205. Kim KJ, Choi JS, Kang I, et al. Melatonin suppresses tumor progression by reducing angiogenesis stimulated by HIF-1 in a mouse tumor model. J Pineal Res 2013; 54: 264-270.
206. Okatani Y, Wakatsuki A, Reiter RJ, et al. Protective effect of melatonin against mitochondrial injury induced by ischemia and reperfusion of rat liver. Eur J Pharmacol 2003; 469: 145-152. (Pubitemid 36629560)
207. Watanabe K, Wakatsuki A, Shinohara K, et al. Maternally administered melatonin protects against ischemia and reperfusion-induced oxidative mitochondrial damage in premature fetal rat brain. J Pineal Res 2004; 37: 276-280. (Pubitemid 39457049)
208. Dominguez-Rodriguez A, Arroyo-Ucar E, Abreu-Gonzalez P,. Role of melatonin in preventing mitochondrial dysfunction in myocardial ischemia-reperfusion injury. Am J Cardiol 2010; 106: 1521-1522.
209. Petrosillo G, Colantuono G, Moro N, et al. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 2009; 297: H1487-H1493.
210. Giacomo CG, Antonio M,. Melatonin in cardiac ischemia/reperfusion-induced mitochondrial adaptive changes. Cardiovasc Hematol Disord Drug Targets 2007; 7: 163-169. (Pubitemid 47496573)
211. Reiter RJ, Tan DX, Leon J, et al. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 2005; 230: 104-117.
212. Yang Y, Duan W, Jin Z, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res 2013; 55: 275-286.
213. Mediavilla MD, Sanchez-Barcelo EJ, Tan DX, et al. Basic mechanisms involved in the anti-cancer effects of melatonin. Curr Med Chem 2010; 17: 4462-4481.
214. Reiter RJ, Tan DX, Sainz RM, et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs. J Pharm Pharmacol 2002; 54: 1299-1321. (Pubitemid 35174175)